HLA-F Antikörper
-
- Target Alle HLA-F (HLAF) Antikörper anzeigen
- HLA-F (HLAF) (HLA Class I alpha F (HLAF))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HLA-F Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Immunogen
- major histocompatibility complex, class I, F
- Isotyp
- IgG
- Top Product
- Discover our top product HLAF Primärantikörper
-
-
- Applikationshinweise
- WB : 1:200-1:2000 IHC : 1:20-1:200
- Kommentare
-
A431 cells were subjected to SDS PAGE followed by western blot with FNab03911(HLA-F antibody) at dilution of 1:500
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze / thaw cycles.
- Lagerung
- -20 °C
- Haltbarkeit
- 12 months
-
- Target
- HLA-F (HLAF) (HLA Class I alpha F (HLAF))
- Andere Bezeichnung
- HLA-F (HLAF Produkte)
- Synonyme
- HLAF antikoerper, CDA12 antikoerper, HLA-5.4 antikoerper, HLA-CDA12 antikoerper, major histocompatibility complex, class I, F antikoerper, HLA-F antikoerper
- Hintergrund
- Synonyms:HLA-5.4, HLAF Background:Involved in the presentation of foreign antigens to the immune system.
- Molekulargewicht
- 45 kDa
- Gen-ID
- 3134
- UniProt
- P30511
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-